Cann Group Ltd (ASX: CAN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Cann Group Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $115.31 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 351.36 million
Earnings per share -0.075
Dividend per share N/A
Year To Date Return 8.62%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Cann Group Ltd (ASX: CAN)
Latest News

A women cheers with clenched fists having read some good news on her laptop.
Share Gainers

Why Argosy Minerals, Cann, OZ Minerals, and PointsBet shares are pushing higher

These ASX shares are having strong days...

Read more »

Rising cannabis share price.
Cannabis Shares

Why is the Cann share price smoking out the ASX by 20% today

Cann shares are in the green on Thursday.

Read more »

A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
Cannabis Shares

Remember when ASX cannabis shares were smoking hot? Where are they now?

Newly legalised recreational and medicinal marijuana markets aren't getting the media hype they once did.

Read more »

Man holding medical cannabis.
Cannabis Shares

ASX cannabis shares in spotlight amid COVID prevention research

Scientists are casting a wide net in the global fight to contain the pandemic.

Read more »

cannabis farmer in the fields checking the crops
Share Gainers

Beaten up ASX cannabis shares showing signs of life

Beaten up ASX cannabis shares are moving higher this week.

Read more »

cannabis brownies and joints surrounded by dollar bills
Cannabis Shares

ASX cannabis shares eyeing $63 billion in legal global sales

Global perceptions of cannabis have come a long way since the 1960s...

Read more »

shadow of a man looking out a window with arrows signifying falling share price
Share Fallers

Why a2 Milk, Cann, Flight Centre, & GPT shares are tumbling lower

These ASX shares are under pressure on Monday...

Read more »

asx share price represented by green cannabis leaf sitting atop red maple leaves
Capital Raising

Cann (ASX:CAN) share price crashes 14% after announcing another capital raising

This cannabis company will soon have raised more money than its market capitalisation...

Read more »

CAN ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Cann Group Ltd

Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.

CAN Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
04 Jul 2022 $0.32 $-0.01 -3.13% 1,017,163 $0.33 $0.35 $0.31
01 Jul 2022 $0.32 $0.05 18.18% 1,508,772 $0.30 $0.34 $0.29
30 Jun 2022 $0.28 $0.05 21.74% 2,366,181 $0.25 $0.30 $0.25
29 Jun 2022 $0.23 $-0.01 -4.17% 1,002,849 $0.24 $0.24 $0.23
28 Jun 2022 $0.24 $0.00 0.00% 417,896 $0.24 $0.25 $0.24
27 Jun 2022 $0.24 $-0.01 -4.00% 475,632 $0.25 $0.25 $0.24
24 Jun 2022 $0.25 $0.01 4.17% 431,426 $0.25 $0.26 $0.25
23 Jun 2022 $0.24 $-0.01 -4.00% 431,842 $0.25 $0.26 $0.24
22 Jun 2022 $0.25 $0.01 4.08% 670,652 $0.25 $0.27 $0.25
21 Jun 2022 $0.25 $0.00 0.00% 709,958 $0.24 $0.26 $0.24
20 Jun 2022 $0.25 $-0.03 -11.11% 1,197,699 $0.27 $0.28 $0.25
17 Jun 2022 $0.27 $-0.01 -3.57% 196,157 $0.28 $0.28 $0.27
16 Jun 2022 $0.28 $0.01 3.64% 479,757 $0.27 $0.28 $0.27
15 Jun 2022 $0.28 $0.00 0.00% 200,109 $0.28 $0.28 $0.27
14 Jun 2022 $0.28 $-0.02 -6.78% 1,219,457 $0.28 $0.29 $0.27
10 Jun 2022 $0.30 $-0.01 -3.33% 887,777 $0.30 $0.30 $0.29
09 Jun 2022 $0.30 $-0.01 -3.23% 228,032 $0.31 $0.31 $0.30
08 Jun 2022 $0.31 $-0.01 -3.17% 124,108 $0.32 $0.32 $0.31
07 Jun 2022 $0.32 $-0.01 -3.08% 66,904 $0.33 $0.33 $0.31

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
07 Sep 2021 Douglas (Doug) Rathbone Buy 363 $100,000
Placement.
07 Sep 2021 Allan McCallum Buy 545 $150,000
Placement.
07 Sep 2021 John Sharman Buy 72 $20,000
Placement.
07 Sep 2021 Philip Jacobsen Buy 2 $750,000
Placement.
07 Sep 2021 Geoffrey(Geoff) Pearce Buy 181 $50,000
Placement.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Douglas (Doug) John Rathbone Non-Executive Director Mar 2015
Mr Rathbone is an experienced public company director and is a former Board member of the FERNZ Corporation and the CSIRO. He is Chairman of the Rathbone Wine Group and Chairman since 1 April 2018, Go Resources, Queenscliff Harbour Pty Ltd and AgBiTech. He is also a former member of the RABO Bank Advisory Board, an Honorary Life Governor of the Royal Children's Hospital and a former Director of the Burnett Centre for Medical Research. Doug brings to the Board experienced management and corporate governance skills together with a passion to grow the business having successfully transformed Nufarm to become one of the world's leading crop protection and seed companies with an global footprint. He is also member of Risk and Capital Committees.
Mr Allan D McCallum Non-Executive ChairmanNon-Executive Director Jan 2015
Mr McCallum has broad experience as a public company director in agribusiness and healthcare and have experience in strategy development and implementation and mergers and acquisitions. He is also member of Risk Committee and chairman of Capital Committees.
Mr John Stewart Sharman Non-Executive Director Apr 2021
Mr Sharman has an international business experience as a Managing Director, CEO, CFO and non-executive director with public and private companies, including several ASX listed entities. He has an understanding of the medical manufacturing industry as well as the pharmaceutical and nutraceutical sectors. He has led businesses with operations in Australia, the UK, Europe, Asia and the USA, building distribution, sales, marketing and manufacturing networks both locally and internationally. Mr Sharman is currently the CEO of Universal Biosensors Inc (ASX:UBI). Prior to that he served 10 years as CEO of Medical Developments International (ASX:MVP). Previous roles included Managing Director of CVC Venture Managers (private equity managers), Managing Director of Vita Life Sciences (ASX:VSC) and Cyclopharm (ASX:CYC), as well as roles at PriceWaterhouseCoopers, National Australia Bank and KPMG in both London and Melbourne.
Ms Jennifer (Jenni) Pilcher Non-Executive Director Sep 2020
Ms Pilcher has senior executive experience in the medical and biotechnology sectors and is currently the Chief Financial Officer and Company Secretary of Mach7 Technologies (ASX:M7T). She has previously held executive roles with Alchemia Limited (ASX:ACL) and Mesoblast Limited (ASX:MSB).
Mr Peter Crock Chief Executive Officer
-
Ms Geraldine Farrell Company Secretary Dec 2019
-
Peter Crock Chief Executive Officer
-
Greg Bullock Chief Financial Officer
-
Shane Duncan Chief Operating Officer
-
Geoff Aldred Chief Projects & Information Officer
-
Geraldine Farrell Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
National Nominees Limited 9,202,765 2.96%
Mr Philip Jacobsen & Mrs Maxine Jacobsen 6,319,518 2.03%
Flag Capital Pty Ltd 6,114,881 1.97%
Mullacam Pty Ltd 5,155,000 1.66%
Supernova Fund Pty Ltd 3,590,909 1.16%
Citicorp Nominees Pty Limited 2,987,457 0.96%
HSBC Custody Nominees (Australia) Limited 2,703,456 0.87%
Harvest One Cannabis Inc 2,248,615 0.72%
Invia Custodian Pty Limited 2,225,395 0.72%
Hardmail Pty Ltd 1,931,852 0.62%
Ms Samira Oliveira Vescovi 1,800,000 0.58%
Commonwealth Scientific And 1,675,533 0.54%
Industrial Research Organisation 1,525,000 0.49%
BNP Paribas Nominees Pty Ltd 1,350,000 0.43%
Australian Businesspoint Pty Ltd 1,250,000 0.40%
Mr Raymond Thomas Hobson & Mrs Rhonda Ellen Hobson 1,200,000 0.39%
Ms Lifang Hao 1,200,000 0.39%
Egea Pty Ltd 1,149,050 0.37%
Estelville Nominees Proprietary Limited 1,127,148 0.36%
BNP Paribas Nominees Pty Ltd Six Sis Ltd 1,062,000 0.34%

Profile

since

Note